Physician profile
Natalie A Doyle
NPI 1932104940
$1,239.48
in general payments reported to CMS, 2019-2025
20 companies · $54.39 in 2025
The $54.39 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $533 · 2020: $366 · 2021: $211 · 2022: $16.05 · 2023: $31.07 · 2024: $27.52 · 2025: $54.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $304.92 | 2019-2022 | |
| Amgen INC. | $142.89 | 2019-2021 | |
| Pfizer INC. | $129.26 | 2019-2025 | |
| Genentech USA, INC. | $103.88 | 2019 | |
| Lilly USA, LLC | $74.07 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $59.99 | 2019-2020 | |
| Melinta Therapeutics, LLC | $57.51 | 2019 | |
| Merck Sharp & Dohme LLC | $50.95 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $50.58 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $44.71 | 2019 | |
| Sanofi-Aventis U.S. LLC | $31.11 | 2019 | |
| Lundbeck LLC | $27.52 | 2024 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.35 | 2020-2021 | |
| Allergan, INC. | $27.09 | 2020 | |
| Dexcom, INC. | $24.84 | 2025 | Dexcom G6 Transmitter |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $20.37 | 2019 | |
| Novartis Pharmaceuticals Corporation | $17.92 | 2019 | |
| Medtronic, INC. | $17.73 | 2023 | Intellis Adaptivestim |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.94 | 2019 | |
| Amarin Pharma, INC. | $12.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Doyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.